364 related articles for article (PubMed ID: 11441109)
21. Severity of murine collagen-induced arthritis correlates with increased CYP7B activity: enhancement of dehydroepiandrosterone metabolism by interleukin-1beta.
Dulos J; Verbraak E; Bagchus WM; Boots AM; Kaptein A
Arthritis Rheum; 2004 Oct; 50(10):3346-53. PubMed ID: 15476247
[TBL] [Abstract][Full Text] [Related]
22. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
Grevers LC; van Lent PL; Koenders MI; Walgreen B; Sloetjes AW; Nimmerjahn F; Sjef Verbeek J; van den Berg WB
Arthritis Rheum; 2009 Feb; 60(2):396-407. PubMed ID: 19180490
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis.
Lee JH; Cho ML; Kim JI; Moon YM; Oh HJ; Kim GT; Ryu S; Baek SH; Lee SH; Kim HY; Kim SI
J Rheumatol; 2009 Apr; 36(4):684-92. PubMed ID: 19228664
[TBL] [Abstract][Full Text] [Related]
24. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
25. Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice.
de Hooge AS; van de Loo FA; Bennink MB; Arntz OJ; Fiselier TJ; Franssen MJ; Joosten LA; Van Lent PL; Richards CD; van den Berg WB
Arthritis Rheum; 2003 Jun; 48(6):1750-61. PubMed ID: 12794844
[TBL] [Abstract][Full Text] [Related]
26. IVIG ameliorate inflammation in collagen-induced arthritis: projection for IVIG therapy in rheumatoid arthritis.
Halpert G; Katz I; Shovman O; Tarasov S; Ganina KK; Petrova N; Tocut M; Volkov A; Barshack I; Blank M; Amital H
Clin Exp Immunol; 2021 Mar; 203(3):400-408. PubMed ID: 33020923
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritis.
Marijnissen RJ; Roeleveld DM; Young D; Nickerson-Nutter C; Abdollahi-Roodsaz S; Garcia de Aquino S; van de Loo FA; van Spriel AB; Boots AM; van den Berg WB; Koenders MI
Arthritis Rheumatol; 2014 Apr; 66(4):886-95. PubMed ID: 24757141
[TBL] [Abstract][Full Text] [Related]
28. A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis.
Arntz OJ; Geurts J; Veenbergen S; Bennink MB; van den Brand BT; Abdollahi-Roodsaz S; van den Berg WB; van de Loo FA
Arthritis Res Ther; 2010; 12(2):R61. PubMed ID: 20370892
[TBL] [Abstract][Full Text] [Related]
29. Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts.
Yamamoto A; Fukuda A; Seto H; Miyazaki T; Kadono Y; Sawada Y; Nakamura I; Katagiri H; Asano T; Tanaka Y; Oda H; Nakamura K; Tanaka S
Arthritis Rheum; 2003 Sep; 48(9):2682-92. PubMed ID: 13130489
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
[TBL] [Abstract][Full Text] [Related]
31. A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL.
Hui W; Cawston TE; Richards CD; Rowan AD
Arthritis Res Ther; 2005; 7(1):R57-64. PubMed ID: 15642143
[TBL] [Abstract][Full Text] [Related]
32. Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18.
Wei XQ; Leung BP; Arthur HM; McInnes IB; Liew FY
J Immunol; 2001 Jan; 166(1):517-21. PubMed ID: 11123331
[TBL] [Abstract][Full Text] [Related]
33. IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis.
Woods JM; Katschke KJ; Volin MV; Ruth JH; Woodruff DC; Amin MA; Connors MA; Kurata H; Arai K; Haines GK; Kumar P; Koch AE
J Immunol; 2001 Jan; 166(2):1214-22. PubMed ID: 11145704
[TBL] [Abstract][Full Text] [Related]
34. Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis.
Van Lent PL; Holthuysen AE; Van Rooijen N; Van De Putte LB; Van Den Berg WB
Ann Rheum Dis; 1998 Jul; 57(7):408-13. PubMed ID: 9797567
[TBL] [Abstract][Full Text] [Related]
35. [Proinflammatory cytokine interleukin-17 and its role in pathogenesis of rheumatoid arthritis].
Leonaviciene L; Bradūnaite R; Astrauskas V
Medicina (Kaunas); 2004; 40(5):419-22. PubMed ID: 15170409
[TBL] [Abstract][Full Text] [Related]
36. Adiponectin exacerbates collagen-induced arthritis via enhancing Th17 response and prompting RANKL expression.
Sun X; Feng X; Tan W; Lin N; Hua M; Wei Y; Wang F; Li N; Zhang M
Sci Rep; 2015 Jun; 5():11296. PubMed ID: 26063682
[TBL] [Abstract][Full Text] [Related]
37. Phagocytic lining cells determine local expression of inflammation in type II collagen-induced arthritis.
van Lent PL; Holthuysen AE; van den Bersselaar LA; van Rooijen N; Joosten LA; van de Loo FA; van de Putte LB; van den Berg WB
Arthritis Rheum; 1996 Sep; 39(9):1545-55. PubMed ID: 8814067
[TBL] [Abstract][Full Text] [Related]
38. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.
Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Kolls JK; Joosten LA; van den Berg WB
Arthritis Rheum; 2005 Mar; 52(3):975-83. PubMed ID: 15751058
[TBL] [Abstract][Full Text] [Related]
39. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
40. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4.
Kim SH; Kim S; Evans CH; Ghivizzani SC; Oligino T; Robbins PD
J Immunol; 2001 Mar; 166(5):3499-505. PubMed ID: 11207309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
